Phenylalanine is an essential, proteinogenic amino acid of the aromatic class (L-phenylalanine). It is obtained from dietary protein sources, incorporated into body proteins, and released during normal protein turnover. Clinically, phenylalanine became important when routine metabolic screening highlighted how changes in its blood levels reflect underlying differences in amino-acid handling and metabolism. Biochemically, phenylalanine is a precursor to tyrosine and several downstream signaling molecules. Its conversion requires specific enzyme activity and cofactors; variations in those pathways or cofactor availability alter how much phenylalanine is retained versus converted. Because it links protein nutrition with neurotransmitter precursor pools and nitrogen balance, phenylalanine is a useful marker for metabolic state and biochemical flux.

Elevated blood phenylalanine can reflect reduced conversion to downstream products, genetic variations in metabolic enzymes, limited cofactor availability, increased protein breakdown, high dietary intake, or altered liver or renal processing. Low phenylalanine may indicate insufficient dietary intake, increased utilization or diversion into downstream pathways, accelerated clearance, or analytical variability. Interpretation is most accurate when considered alongside related amino acids, nutrient cofactors, liver markers, and genetic results on the full Nutrient Zoomer panel.

Phenylalanine is included in the Nutrient Zoomer to evaluate amino acid sufficiency and precursor availability for neurotransmitter and protein synthesis. It helps reveal metabolic bottlenecks, cofactor needs, and genetic influences on amino-acid handling, enabling providers to identify patterns of imbalance and tailor individualized nutrition strategies.